\
&
Contact us
\
&
Contact us
This was 3 years ago
LocationParis
As part of the French presidency of the EU, a meeting between policy makers and researchers from EU countries on the Mission on Cancer is organised in Paris. The meeting will focus on European advances in the understanding of cancer. Among the speakers are European Commissioner for Research & Innovation Mariya Gabriel and European Commissioner for Health and Food Safety Stella Kyriakides. Also on the programme is a panel discussion between workpackage leaders of 4.UNCAN.eu and European Commission representatives.
The meeting is open to all and free of charge. Registration is mandatory (as places are limited).
More information, the detailed programme and registration on the event website.
The event is organised by Aviesan, the French National Alliance for Life Sciences and Health and INCA, the French National Cancer Institute.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
